2 results
Approved WMORecruiting
The aim of this study is to examine the effectiveness of treatment with tDCS in reducing AVH and related symptoms in patients with BPD and AVH
Approved WMORecruiting
The purpose of this study is to assess whether a new combination treatment (Savolitinib and Durvalumab) is better than standard treatment sunitinib in MET-driven PRCC. The study will also assess the contribution of one part of the combination (…